Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease ...

Campaigners have blasted the move as a "major disappointment”.

Biogen Inc. (NASDAQ:BIIB) on Friday reported better-than-expected fourth-quarter earnings, with adjusted EPS of $1.99, ...

A mathematical model simulated patient outcomes when given caregiver support or an expensive Alzheimer’s drug to determine cost and health benefits.

The Scottish Medicines Consortium has rejected donanemab for early Alzheimer’s disease, citing inadequate clinical and economic evidence.

A global expert review has identified a shingles vaccine and two existing drugs as leading candidates for repurposing against ...

A new study finds THC, when combined with an anti-inflammatory drug, improved memory and reduced Alzheimer’s-related brain damage in mice, raising hope for future treatment.

One of the first Australians to receive the groundbreaking treatment says it has helped restore clarity, as access and cost ...

China granted Priority Review for an at-home Alzheimer’s treatment developed by Biogen and Eisai. ・If approved, the ...

The burden of Chlamydia pneumoniae was higher in the retina and brain of people with Alzheimer's disease compared with controls, increasing with APOE4, disease stage, and cognitive deficits. ( Nature ...

Despite its strong influence, APOE is not the sole cause of Alzheimer’s or other dementias. Even among people with the highest genetic risk, those who carry two ε4 variants, lifetime risk of Alzheimer ...